| Primary |
| Colitis Ulcerative |
40.6% |
| Product Used For Unknown Indication |
18.9% |
| Crohn's Disease |
17.7% |
| Colitis |
2.9% |
| Hypertension |
2.4% |
| Diverticulitis |
2.3% |
| Drug Use For Unknown Indication |
2.3% |
| Supplementation Therapy |
1.8% |
| Inflammatory Bowel Disease |
1.7% |
| Hypothyroidism |
1.1% |
| Ulcerative Colitis |
1.1% |
| Anal Fissure |
0.9% |
| Deep Vein Thrombosis |
0.9% |
| Proctalgia |
0.9% |
| Rash |
0.9% |
| Sinusitis |
0.9% |
| Hypersensitivity |
0.8% |
| Hypokalaemia |
0.8% |
| Proctocolitis |
0.8% |
| Analgesic Therapy |
0.6% |
|
| Traumatic Lung Injury |
29.9% |
| Weight Decreased |
7.5% |
| Pyrexia |
5.4% |
| Tubulointerstitial Nephritis |
5.4% |
| White Blood Cell Count Increased |
5.4% |
| Thrombocytopenia |
4.8% |
| Abscess |
3.4% |
| Eosinophilic Pneumonia |
3.4% |
| Off Label Use |
3.4% |
| Pancreatitis |
3.4% |
| Pancreatitis Acute |
3.4% |
| Acute Lung Injury |
2.7% |
| Agranulocytosis |
2.7% |
| Gastrointestinal Haemorrhage |
2.7% |
| Myocarditis |
2.7% |
| Myopericarditis |
2.7% |
| Organising Pneumonia |
2.7% |
| Pericardial Effusion |
2.7% |
| Pleurisy |
2.7% |
| Vomiting |
2.7% |
|
| Secondary |
| Crohn's Disease |
34.3% |
| Colitis Ulcerative |
26.3% |
| Product Used For Unknown Indication |
20.6% |
| Inflammatory Bowel Disease |
3.5% |
| Hypertension |
1.8% |
| Rash |
1.7% |
| Drug Use For Unknown Indication |
1.5% |
| Deep Vein Thrombosis |
1.4% |
| Foetal Exposure During Pregnancy |
1.4% |
| Colitis |
1.0% |
| Antibiotic Therapy |
0.9% |
| Diverticulitis |
0.8% |
| Hodgkin's Disease Nodular Sclerosis Stage Unspecified |
0.8% |
| Arthritis Enteropathic |
0.7% |
| Diarrhoea Haemorrhagic |
0.6% |
| Hepatosplenic T-cell Lymphoma |
0.6% |
| Listeriosis |
0.6% |
| Meningitis |
0.6% |
| Sinusitis |
0.6% |
| Unevaluable Event |
0.6% |
|
| Pancreatitis Acute |
11.4% |
| Pancreatitis |
10.7% |
| T-cell Lymphoma |
9.3% |
| Diffuse Large B-cell Lymphoma |
7.9% |
| Renal Failure Acute |
7.9% |
| Thrombocytopenia |
5.0% |
| Colitis Ulcerative |
4.3% |
| Crohn's Disease |
4.3% |
| Neutropenic Sepsis |
4.3% |
| Leukopenia |
3.6% |
| Lung Disorder |
3.6% |
| Pericarditis |
3.6% |
| Pyrexia |
3.6% |
| Vomiting |
3.6% |
| Condition Aggravated |
2.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.9% |
| Epstein-barr Virus Test Positive |
2.9% |
| Lymphoma |
2.9% |
| Septic Shock |
2.9% |
| Squamous Cell Carcinoma |
2.9% |
|
| Concomitant |
| Crohn's Disease |
42.6% |
| Product Used For Unknown Indication |
14.2% |
| Drug Use For Unknown Indication |
11.9% |
| Colitis Ulcerative |
10.3% |
| Inflammatory Bowel Disease |
4.0% |
| Hypertension |
1.9% |
| Pain |
1.9% |
| Depression |
1.7% |
| Prophylaxis |
1.4% |
| Rheumatoid Arthritis |
1.4% |
| Colitis |
1.2% |
| Premedication |
1.1% |
| Diarrhoea |
1.1% |
| Vitamin Supplementation |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Osteoporosis |
0.9% |
| Diabetes Mellitus |
0.7% |
| Insomnia |
0.6% |
| Nausea |
0.6% |
| Anaemia |
0.5% |
|
| Crohn's Disease |
23.2% |
| Colitis Ulcerative |
9.0% |
| Vomiting |
7.1% |
| Accidental Exposure |
6.6% |
| Pyrexia |
6.0% |
| Injection Site Pain |
4.7% |
| Weight Decreased |
4.5% |
| Abdominal Pain |
4.3% |
| Intestinal Obstruction |
3.8% |
| Colitis |
3.6% |
| Drug Ineffective |
3.2% |
| Nausea |
3.0% |
| Sepsis |
2.9% |
| Weight Increased |
2.9% |
| Pneumonia |
2.7% |
| Herpes Zoster |
2.6% |
| Infusion Related Reaction |
2.6% |
| Rash |
2.6% |
| Aplastic Anaemia |
2.4% |
| Inflammatory Bowel Disease |
2.4% |
|
| Interacting |
| Colitis Ulcerative |
66.7% |
| Crohn's Disease |
33.3% |
|
| Herpes Zoster |
33.3% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
33.3% |
| Pyrexia |
33.3% |
|
